- Home
- LH vs BAX Comparison
LH vs BAX Comparison
Compare LH & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LH
- BAX
- Stock Information
- Founded
- LH 1971
- BAX 1931
- Country
- LH United States
- BAX United States
- Employees
- LH N/A
- BAX N/A
- Industry
- LH Medical Specialities
- BAX Medical/Dental Instruments
- Sector
- LH Health Care
- BAX Health Care
- Exchange
- LH Nasdaq
- BAX Nasdaq
- Market Cap
- LH 18.8B
- BAX 18.5B
- IPO Year
- LH N/A
- BAX N/A
- Fundamental
- Price
- LH $215.19
- BAX $36.65
- Analyst Decision
- LH Buy
- BAX Hold
- Analyst Count
- LH 16
- BAX 9
- Target Price
- LH $252.60
- BAX $41.78
- AVG Volume (30 Days)
- LH 442.3K
- BAX 3.8M
- Earning Date
- LH 10-24-2024
- BAX 11-08-2024
- Dividend Yield
- LH 1.34%
- BAX 3.17%
- EPS Growth
- LH N/A
- BAX N/A
- EPS
- LH 5.27
- BAX 4.88
- Revenue
- LH $12,487,600,000.00
- BAX $14,997,000,000.00
- Revenue This Year
- LH $9.80
- BAX $3.82
- Revenue Next Year
- LH $5.67
- BAX $3.39
- P/E Ratio
- LH $40.84
- BAX $7.51
- Revenue Growth
- LH 5.22
- BAX 2.90
- 52 Week Low
- LH $191.97
- BAX $31.70
- 52 Week High
- LH $238.47
- BAX $44.01
- Technical
- Relative Strength Index (RSI)
- LH 42.14
- BAX 45.23
- Support Level
- LH $211.28
- BAX $36.31
- Resistance Level
- LH $220.20
- BAX $37.54
- Average True Range (ATR)
- LH 3.22
- BAX 1.03
- MACD
- LH 0.05
- BAX -0.06
- Stochastic Oscillator
- LH 31.01
- BAX 51.05
About LH Laboratory Corporation of America Holdings
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
About BAX Baxter International Inc.
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. It has signed an agreement to sell its kidney care segment by early 2025.